These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 641791)

  • 1. Kinetics of drug transport and concurrent metabolism in human cell cultures I: theory.
    Ando HY; Ho NF; Higuchi WI; Shipman C
    J Pharm Sci; 1978 May; 67(5):606-10. PubMed ID: 641791
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Systems approach to the study of drug transport across membranes using suspension culture of mammalian cells. V. Simultaneous poassive transport and biosynthesis.
    Ando HY; Ho NF; Higuchi WI; Turi J; Shipman C
    J Theor Biol; 1976 Oct; 62(1):211-25. PubMed ID: 994520
    [No Abstract]   [Full Text] [Related]  

  • 3. Systems approach to study of solute transport across membranes using suspension cultures of mammalian cells III: steady-state diffusion models.
    Turi JS; Ho NF; Higuchi WI; Shipman C
    J Pharm Sci; 1975 Apr; 64(4):622-6. PubMed ID: 1142072
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical approximations of sensitivities of steady state predictions to errors in parameter estimation.
    Gonda I
    J Pharmacokinet Biopharm; 1982 Oct; 10(5):559-74. PubMed ID: 7166739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Permeability, transport, and metabolism of solutes in Caco-2 cell monolayers: a theoretical study.
    Sun H; Pang KS
    Drug Metab Dispos; 2008 Jan; 36(1):102-23. PubMed ID: 17932224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enzyme kinetics in drug metabolism: fundamentals and applications.
    Nagar S; Argikar UA; Tweedie DJ
    Methods Mol Biol; 2014; 1113():1-6. PubMed ID: 24523105
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Apparent aberrancy in the kinetics of intracellular metabolism of a single substrate by two enzymes. An alternative explanation for anomalies in the kinetics of sulfation and glucuronidation.
    Koster H; Mulder GJ
    Drug Metab Dispos; 1982; 10(4):330-5. PubMed ID: 6126330
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetics of drug metabolism inhibition: use of metabolite concentration-time profiles.
    Shaw PN; Houston JB
    J Pharmacokinet Biopharm; 1987 Oct; 15(5):497-510. PubMed ID: 3694494
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of total hepatic clearance by combining metabolism, transport, and permeability data in the in vitro-in vivo extrapolation methods: emphasis on an apparent fraction unbound in liver for drugs.
    Poulin P
    J Pharm Sci; 2013 Jul; 102(7):2085-95. PubMed ID: 23613473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of complex formation on drug transport.
    Vaidhyanathan VS
    J Pharm Sci; 1972 Jun; 61(6):894-900. PubMed ID: 5046105
    [No Abstract]   [Full Text] [Related]  

  • 11. Residence time and accumulation of drugs in the body.
    Weiss M
    Int J Clin Pharmacol Ther Toxicol; 1981 Feb; 19(2):82-5. PubMed ID: 7216555
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interplay of transporters and enzymes in drug and metabolite processing.
    Pang KS; Maeng HJ; Fan J
    Mol Pharm; 2009; 6(6):1734-55. PubMed ID: 19891494
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transporters--the view from industry.
    Kohl C
    Chem Biodivers; 2009 Nov; 6(11):1988-99. PubMed ID: 19937835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hurdles with using in vitro models to predict human blood-brain barrier drug permeability: a special focus on transporters and metabolizing enzymes.
    Shawahna R; Decleves X; Scherrmann JM
    Curr Drug Metab; 2013 Jan; 14(1):120-36. PubMed ID: 23215812
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identifiable pharmacokinetic models: the role of extra inputs and measurements.
    Godfrey KR; Jones RP; Brown RF
    J Pharmacokinet Biopharm; 1980 Dec; 8(6):633-48. PubMed ID: 7229913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of drug absorption, distribution, metabolism, and excretion.
    NELSON E
    J Pharm Sci; 1961 Mar; 50():181-92. PubMed ID: 13728276
    [No Abstract]   [Full Text] [Related]  

  • 17. A simple integrated method for drug and derived metabolite kinetics. An application of the statistical moment theory.
    Chan KK
    Drug Metab Dispos; 1982; 10(5):474-9. PubMed ID: 6183086
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design, data analysis, and simulation of in vitro drug transport kinetic experiments using a mechanistic in vitro model.
    Poirier A; Lavé T; Portmann R; Brun ME; Senner F; Kansy M; Grimm HP; Funk C
    Drug Metab Dispos; 2008 Dec; 36(12):2434-44. PubMed ID: 18809732
    [TBL] [Abstract][Full Text] [Related]  

  • 19. General method for evaluating the fraction of the irreversible organ clearance due to conversion of drug to a primary metabolite.
    Bayne WF; Hwang SS
    J Pharm Sci; 1985 Jul; 74(7):722-6. PubMed ID: 4032242
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Should blood transport kinetics be modeled in metabolic processes?
    Belforte G; Bona B; Molino G
    Am J Physiol; 1984 Nov; 247(5 Pt 2):R895-900. PubMed ID: 6496773
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.